438
Views
50
CrossRef citations to date
0
Altmetric
Research Article

The role of hypoxia inducible factor-1α in the increased MMP-2 and MMP-9 production by human monocytes exposed to nickel nanoparticles

, , , , , & show all
Pages 568-582 | Received 04 Nov 2009, Accepted 02 Nov 2010, Published online: 14 Mar 2011

References

  • Belkhiri A, Richars C, Whaley M, McQuwwn, SA, Orr FW. 1997. Increased expression of activated matrix metalloproteinase-2 by human endothelial cells after sublethal H2O2 exposure. Lab Invest 77:533–539.
  • Cammarota M, Lamberti M, Masella L, Galletti P, De Rosa M, Sannolo N, Giuliano M. 2006. Matrix metalloproteinases and their inhibitors as biomarkers for metal toxicity in vitro. Toxicol in Vitro 20:1125–1132.
  • Cauwe B, Van den Steen PE, Opdenakker G. 2007. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 42:113–185.
  • Davidson T, Salnikow K, Costa M. 2003. Hypoxia inducible factor-1 alpha-independent suppression of aryl hydrocarbon receptor-regulated genes by nickel. Mol Pharmacol 64:1485–1493.
  • Dagnell C, Kemi C, Klominek J, Eriksson P, Skold M, Eklund A, Grunewald J, Hoglund CO. 2007. Effects of neurotrophins on human bronchial smooth muscle cell migration and matrix metalloproteinase-9 secretion. Translational Res 150:303–310.
  • Das S, Banerji A, Frei E, Chatterjee A. 2008. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cell (MCF-7) to fibronectin in serum free medium. Life Sci 82:467–476.
  • Elkington PT, O'Kane CM, Friedland JS. 2005. The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol 142:12–20.
  • Ferin J, Oberdöster G, Penney D. 1990. Increased pulmonary toxicity of ultrafine? I. Particle clearance, translocation, morphology. J Aerosol Sci 21:381–384.
  • Frampton MW, Stewart JC, Oberdöster G, Morrow PE, Chalupa D, Pietropaoli AP, Frasier LM, Dpeers DM, Huang LS, Utell MJ. 2006. Inhalation of ultrafine particles alters blood leukocytes expression of adhesion molecules in humans. Environ Health Perspect 114:51–58.
  • Fujiwara S, Nakagawa K, Harada H, Nagato S, Furukawa K, Teraoka M, Seno T, Oka K, Iwata S, Ohnishi T. 2007. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas. Int J Oncol 30:793–802.
  • Galli A, Svegliati-Baroni G, Milani S, Ridolfi F, Salzano R, Tarocchi M, Crappone C, Pellegrini D, Benedetti A, Surrenti C, Casini A. 2005. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. Hepathology 41:1074–1084.
  • Greenlee KJ, Werb Z, Kheradmand F. 2007. Matrix metalloproteinases in lung: Multiple, multifarious, and multifaceted. Physiol Res 87:69–98.
  • Haorah J, Ramirez SH, Schall K, Smith S, Pandya R, Persidsky Y. 2007. Oxidative stress activates protein kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction. J. Neurochem 101:566–576.
  • Hemmerlein B, Johanns U, Halbfass J, Bottcher T, Heuser M, Radzun HJ, Thelen P. 2004. The balance between MMP-2/-9 and TIMP-1/-2 is shifted towards MMP in renal cell carcinomas and can be further disturbed by hydrogen peroxide. Int J Oncol 24:1069–1076.
  • Ho FM, Liu SH, Lin WW, Liau CS. 2007. Opposite effects of high glucose on MMP-2 and TIMP-2 in human endothelial cells. J Cell Biochem 101:442–450.
  • Luo L, Petit A, Antoniou J, Zukor DJ, Huk OL, Liu RCW, Winnik FM, Mwale F. 2005. Effect of cobalt and chromium ions on MMP-1, TIMP-1 and TNF-α gene expression in human U937 macrophages: A role of tyrosine kinases. Biomaterials 26:5587–5593.
  • Liu YV, Baek JH, Zhang H, Diez R, Cole RN, Semenza GL. 2007. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Mol Cell 25:207–217.
  • Lu Y, Wahl LM. 2005. Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-kappa B activity in lipopolysaccharide-activated human primary monocytes. J Immunol 175:5423–5429.
  • Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. 1999. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271–275.
  • Maxwell P, Salnikow K. 2004. HIF-1: An oxygen and metal responsive transcription factor. Cancer Biol Ther 3:29–35.
  • Milkiewicz M, Haas TL. 2005. Effect of mechanical stretch on HIF-1{alpha} and MMP-2 expression in capillaries isolated from overloaded skeletal muscles: Laser capture microdissection study. Am J Physiol Heart Circ Physiol 289:H1315–1320.
  • Minet E, Mottet D, Michel G, Roland I, Raes M, Remacle J. Michiels C. 1999. Hypoxia-induced activation of HIF-1: Role of HIF-1alpha-Hsp90 interaction. FEBS Lett 460:251–256.
  • Misra S, Fu AA, Rajan DK, Juncos LA, McKusick MA, Bjarnason H, Mukhopadhyay D. 2008. Expression of hypoxia inducible factor-1 alpha, macrophage migration inhibition factor, matrix metalloproteinase-2 and -9, and their inhibitors in hemodialysis grafts and arteriovenous fistulas. J Vasc Interv Radiol 19:252–259.
  • Mo Y, Zhu X, Hu X, Tollerud DJ, Zhang Q. 2008. Cytokine and NO release from peripheral blood neutrophils after exposure to metal nanoparticles: In vitro and ex vivo studies. Nanotoxicology 2:79–87.
  • Mo Y, Wan R, Chien S, Tollerud DJ, Zhang Q. 2009. Activation of endothelial cells after exposure to ambient ultrafine particles: the role of NADPH oxidase. Toxicol Appl Pharmacol 236(2):183–193.
  • Murphy G, Willenbrock F, Crabbe T, O'Shea M, Ward R, Atkinson S, O'Connell J, Docherty A. 1994. Regulation of matrix metalloproteinase activity. Ann NY Acad Sci 994(732):31–41.
  • Neckers L, Ivy SP. 2003. Heat shock protein 90. Curr Opin Oncol 25:419–424.
  • Nemmar A, Vanbilloen H, Hoylaerts, MF, Hoet PHM, Verbruggen A, Nemery B. 2001. Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamsters. Am J Respir Crit Care Med 164:1665–1668.
  • Nemmar A, Hoet PHM, Vanquickenborme B, Dinsdale D, Thomeer M, Hoylaerts MF, Vanbilloen H, Mortelmans L, Nemery B. 2002. Passage of inhaled particles into the blood circulation in human. Circulation 105:411–414.
  • Oberdörster G. 2001. Pulmonary effects of inhaled ultrafine particles. Int Arch Occup Environ Heal 74:1–8.
  • Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, Kreyling W. Cox C. 2002. Extra-pulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure rats. J Toxicol Environ Health A 65:1531–1543.
  • Oberdörster G, Utell MJ. 2002. Ultrafine particles in the urban air: To the respiratory tract – and beyond? Environ Heal Perspect 110:A440–441.
  • Oum'hamed Z, Garnotal R, Josset Y, Trenteseaux C, Lauren-Maquin D. 2004. Matrix metalloproteinases MMP-2, -9 and tissue inhibitors TIMP-1, -2 expression and secretion by primary human osteoblast cells in response to titanium, zirconia, and alumina ceramics. J Biomed Mater Res 68A:114–122.
  • Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJ. 1997. Matrix metalloproteinase. Br J Surg 84:160–166.
  • Parks WC, Shapiro SD. 2001. Matrix metalloproteinases in lung biology. Respir Res 2:10–19.
  • Parks WC. 2003. Matrix metalloproteinases in lung repair. Eur Respir J (Suppl. 44):36s–38s.
  • Perfetto B, Lamberti M, Giuliano MT, Canozo N, Cammarota M, Baroni A. 2007. Analysis of the signal transduction pathway of nickel-induced matrix metalloproteinase-2 expression in human keratinocytes in vitro: Preliminary findings. J Gutan Pathol 34:441–447.
  • Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. 1996. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability 98:2572–2579.
  • Salnikow K, Davidson T, Costa M. 2002. The role of hypoxia-inducible signaling pathway in nickel carcinogenesis. Environ Health Perspect 110(Suppl. 5):831–834.
  • Salnikow K, Davidson T, Zhang Q, Chen LC, Su W, Costa M. 2003. The involvement of hypoxia-inducible transcription factor-1-dependent pathway in nickel carcinogenesis. Cancer Res 63:3524–3530.
  • Serita F, Kyono H, Seki Y. 1999. Pulmonary clearance and lesions in rats after a single inhalation of ultrafine metallic nickel at dose levels comparable to the threshold limit value. Ind Health 37:353–363.
  • Shi YF, Fong CC, Zhang Q, Cheung PY, Tzang CH, Wu RS, Yang M. 2007. Hypoxia induces the activation of human hepatic stellate cells LX-2 through TGF-beta signaling pathway. FEBS Lett 581:203–210.
  • Siwik DA, Pagano PJ, Colucci WS. 2001. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 280:C53–60.
  • Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J. 2001. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 109(Suppl. 4):547–551.
  • Togawa D, Koshino T, Saito T, Takagi T, Machida J. 1999. Highly activated matrix metalloproteinase-2 secreted from clones of metastatic lung nodules of nude mice injected with human fibrosarcoma HT1080. Cancer Letter 146:25–33.
  • Valentin F, Bueb JL, Kieffer P, Tschirhart E, Atkinson J. 2005. Oxidative stress activates MMP-2 in cultured human coronary smooth muscle cells. Fundam Clin Pharmacol 19:661–667.
  • Wan R, Mo Y, Zhang X, Chien S, Tollerud DJ, Zhang Q. 2008. Matrix metalloproteinase-2 and -9 are induced differently by metal nanoparticles in human monocytes: The role of oxidative stress and protein tyrosine kinase activation. Toxicol Appl Pharmacol 233:276–285.
  • Wang GL, Semenza GL. 1993a. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 90:4304–4308.
  • Wang GL, Semenza GL. 1993b. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 268:21513–21518.
  • Wang GL, Jiang BH, Rue EA, Semenza GL. 1995. Hypoxia-inducible factor 1 is a basichelix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:5510–5514.
  • Whitesell L, Lindquist SL. 2005. HSP90 and the chaperoning of cancer. Nat Rev Cancer 5:761–772.
  • Yamashita K, Discher DJ, Hu J, Bishopric NH, Webster KA. 2001. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. J Biol Chem 276:12645–12653.
  • Yang C, Zeng S, Lv M. 2006. Effect of shRNA inhibiting HiF1alpha gene on TIMP1 expression in RPE cells. J Huazhong Univ Sci Technolog Med Sci 26:133–136.
  • Yu M, Mo Y, Wan R, Chien S, Zhang X, Zhang Q. 2010. Regulation of plasminogen activator inhibitor-1 expression in endothelial cells with exposure to metal nanoparticles. Toxicol Lett 195:82–89.
  • Zeng H, Briske-Anderson M. 2005. Prolonged butyrate treatment inhibits the migration and invasion potential of HT1080 tumor cells. J Nutr 135:291–295.
  • Zhang HJ, Zhao W, Venkararaman S, Robbins ME, Buetter GR, Kregel KC, Oberley LW. 2002. Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species. J Biol Chem 277:20919–20926.
  • Zhang Q, Kusaka Y, Sato K, Nakakuki K, Koyama N, Donaldson K. 1998a. Differences in the extent of inflammation caused by intratracheal exposure to three ultrafine metals: Role of free radical. J Toxicol Environ Health 53:423–438.
  • Zhang Q, Kusaka Y, Sato K, Mo Y, Fukuda M, Donaldson K. 1998b. Toxicity of ultrafine nickel particle in lung after intratracheal instillation. J Occup Health 40:171–176.
  • Zhang Q, Kusaka Y, Zhu X, Sato K, Mo Y, Kluz T, Donaldson K. 2003. Comparative toxicity of standard nickel and ultrafine nickel in lung after intratracheal instillation. J Occup Health 45:20–32.
  • Zhao J, Chen H, Davidson T, Kluz T, Zhang Q, Costa M. 2004. Nickel-induced 1, 4-alphaglucan branching enzyme 1 up-regulation via the hypoxic signaling pathway. Toxicol Appl Pharmacol 196:404–409.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.